116 related articles for article (PubMed ID: 4046498)
1. Human smooth muscle cells of the aorta and vena cava: different sensitivity to the inhibition of proliferation by heparin in vitro.
Thilo-Körner DG; Bödeker RH
Klin Wochenschr; 1985 Aug; 63(15):702-5. PubMed ID: 4046498
[TBL] [Abstract][Full Text] [Related]
2. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
3. Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells.
Patel RC; Handy I; Patel CV
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1439-44. PubMed ID: 12231563
[TBL] [Abstract][Full Text] [Related]
4. Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cells.
Hajjar DP; Boyd DB; Harpel PC; Nachman RL
J Exp Med; 1987 Mar; 165(3):908-13. PubMed ID: 3819648
[TBL] [Abstract][Full Text] [Related]
5. Derivatized dextran inhibition of smooth muscle cell proliferation.
Avramoglou T; Jozefonvicz J
J Biomater Sci Polym Ed; 1991; 3(2):149-54. PubMed ID: 1722699
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
7. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
8. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
9. O-acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase alpha-smooth muscle actin expression in cultured arterial smooth muscle cells.
Bârzu T; Desmoulière A; Herbert JM; Level M; Herault JP; Petitou M; Lormeau JC; Gabbiani G; Pascal M
Eur J Pharmacol; 1992 Aug; 219(2):225-33. PubMed ID: 1425951
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin.
Herman IM
Haemostasis; 1990; 20 Suppl 1():166-77. PubMed ID: 2083870
[TBL] [Abstract][Full Text] [Related]
11. Dual effect of heparin and low molecular weight heparin on cultured smooth muscle cells.
Cong XF; Liu XW; Peng Y; Chang YS
Hypertens Res; 2000 Jul; 23(4):381-4. PubMed ID: 10912777
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin.
Völker W; Böhm A; Schmidt A; Svahn CM; Gellerbring AK; Mattsson C; Ekvärn S; Robenek H; Buddecke E
Arzneimittelforschung; 1995 May; 45(5):546-50. PubMed ID: 7612053
[TBL] [Abstract][Full Text] [Related]
13. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells.
Castellot JJ; Pukac LA; Caleb BL; Wright TC; Karnovsky MJ
J Cell Biol; 1989 Dec; 109(6 Pt 1):3147-55. PubMed ID: 2592420
[TBL] [Abstract][Full Text] [Related]
14. Influence of inhibitors of thrombin on porcine aortic smooth muscle cells in primary culture.
Melzig M; Harms C; Teuscher E; Voigt B; Wagner G
Biomed Biochim Acta; 1986; 45(9):1199-202. PubMed ID: 3814109
[TBL] [Abstract][Full Text] [Related]
15. Effects of heparinoids on the sclerotic reaction of rat thoracic aorta to injury: comparison between standard and low-molecular-weight heparins in vitro and in vivo.
Chajara A; Heudes D; Peronneau I; Jarnet J; Basset A; Capron L
J Cardiovasc Pharmacol; 1994 Jun; 23(6):995-1003. PubMed ID: 7523793
[TBL] [Abstract][Full Text] [Related]
16. Heparin induces synthesis of highly charged heparan sulphate by vascular smooth muscle cells.
Mason RM; Williams SP
Biochem Soc Trans; 1990 Oct; 18(5):965. PubMed ID: 2083770
[No Abstract] [Full Text] [Related]
17. Mechanical behavior of vessel wall: a comparative study of aorta, vena cava, and carotid artery.
Silver FH; Snowhill PB; Foran DJ
Ann Biomed Eng; 2003; 31(7):793-803. PubMed ID: 12971612
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of smooth muscle cell proliferation by heparin molecules.
Clowes AW; Clowes MM
Transplant Proc; 1989 Aug; 21(4):3700-1. PubMed ID: 2763338
[No Abstract] [Full Text] [Related]
19. Regulation of smooth muscle proliferation by heparin in vitro and in vivo.
Clowes AW; Clowes MM
Int Angiol; 1987; 6(1):45-51. PubMed ID: 3624946
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in the response of vascular smooth muscle to heparin: altered signaling in heparin-resistant cells.
Templeton DM; Zhao Y; Fan MY
Cardiovasc Res; 2000 Jan; 45(2):503-12. PubMed ID: 10728372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
